Abstract
Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Medicinal Chemistry
Title:Essential Structural Features of Novel Antischizophrenic Drugs: A Review
Volume: 10 Issue: 6
Author(s): Alireza Nematollahi, Noushin Aminimoghadamfarouj and William Bret Church
Affiliation:
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Abstract: Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Export Options
About this article
Cite this article as:
Nematollahi Alireza, Aminimoghadamfarouj Noushin and Church Bret William, Essential Structural Features of Novel Antischizophrenic Drugs: A Review, Medicinal Chemistry 2014; 10 (6) . https://dx.doi.org/10.2174/1573406410666131229150746
DOI https://dx.doi.org/10.2174/1573406410666131229150746 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intravenous Immunoglobulin Preparations: Quality Assurance Measures and Proposed Strategies for Improving its Safe and Judicious use in India
Applied Clinical Research, Clinical Trials and Regulatory Affairs Preface: (A Historical Prespective) to CPC’s 6<sup>th</sup> Year, 2016 (A New Beginning)
Current Physical Chemistry Post-stroke Engagement-sensitive Balance Rehabilitation Under An Adaptive Multi-level Electrotherapy: Clinical Hypothesis and Computational Framework
Neuroscience and Biomedical Engineering (Discontinued) Roles of Casein Kinase I η and δ in Gastrointestinal Cancers: Potential New Screening Markers and Drug Targets
Current Cancer Therapy Reviews Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Advances in Drug Safety
Current Pharmaceutical Design Ginkgo Biloba Extract in an Animal Model of Parkinson’s Disease: A Systematic Review
Current Neuropharmacology Hierarchically Organized Nanocomposites Derived from Low-dimensional Nanomaterials for Efficient Removal of Organic Pollutants
Current Organic Chemistry Collateral Circulation in Chronic Total Occlusions – an interventional perspective
Current Cardiology Reviews Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Heme Oxygenase-1 against Vascular Insufficiency: Roles of Atherosclerotic Disorders
Current Pharmaceutical Design Histamine H3 Receptor Function and Ligands: Recent Developments
Mini-Reviews in Medicinal Chemistry The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain
Current Neuropharmacology The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Fitness or Fatness: The Debate Continues for AMP-Activated Protein Kinase in Heart Function
Current Cardiology Reviews Transcranial Direct Current Stimulation for the Treatment of Addictions: A Systematic Review of Clinical Trials
Current Psychiatry Reviews Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Current Neuropharmacology Quantitative Imaging Biomarkers and their Emerging Role
Current Medical Imaging From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Current Psychopharmacology Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases
Current Pharmaceutical Design